PTSD

References

Brady KT.  Post-traumatic stress disorder  post-traumatic stress  disorderand comorbidity: recognising the many faces of PTSD.  J Clin Psychiatry 1997; 58 (Suppl 9): 12–15.

Braun P, Greenberg D, Daaberg H, Lerer B.  Core symptoms of post-traumatic stress disorder  unimproved by alprazolam.  J Clin Psychiatry 1990; 51: 236–238.

Breslau N, Kessler RC, Chilcoat HD, Schultz LR, Davis GC, Andreski P.  Trauma and post-traumatic stress  disorder in the community: the 1996 Detroit area survey of trauma.  Arch Gen Psychiatry 1998; 55: 626–632.

Charney DS, Deutsch AY, Krystal JH, Southwick SM, Davis M.  Psychobiologic mechanisms of post-traumatic stress  disorder.  Arch Gen Psychiatry 1993; 50: 295–305.

Davidson JRT.  Biological therapies for post-traumatic stress  disorder: an overview.  J Clin Psychiatry 1997; 58 (Suppl 9): 29–32.

Davidson JRT, Roth S, Newman E.  Fluoxetine in post-traumatic stress  disorder.  J Trauma Stress  1991; 4: 419–423.

Davidson JRT, Weisler RH, Malik MH, Connor MK.  Treatment of post-traumatic stress  disorder with nefazodone.  Int Clin Psychopharmacol 1998; 13: 111–113.

Davis LL, Suris A, Lambert MT, Heimberg C, Petty F.  Post-traumatic stress  disorder and serotonin: new directions for research and treatment.  J Psychiatry Neurosci 1997; 22: 318–326.

De Boer M, Op den Velde W, Falger RJR et al.  Fluvoxamine treatment of chronic PTSD.  Psychother Psychosom 1991; 57: 158–163.

Dow B, Kline N.  Antidepressant treatment of post-traumatic stress  disorder and major depression  in veterans.  Ann Clin Psychiatry 1997; 9: 1–5.

Ebbinghaus R, Bauer M, Priebe S.  Behandlung der posttraumatischen Belastungsstorung.  Fortschr Neurol Psychiatr 1996; 64: 433–443.

Foa EB, Olasov Rothbaum B, Riggs DS, Murdock TB.  Treatment of post-traumatic stress  disorder in rape victims: a comparison between cognitive -behavioural procedures and counselling.  J Consult Clin Psychol 1991; 59: 715–723.

Helzer JE, Robins LN, McEvoy L.  Post-traumatic stress  disorder in the general population.  Findings of the epidemiological catchment area survey.  N Engl J Med 1987; 317: 1630–1634.

Hensman R, Guimaraes FS, Wang M, Deakin JFW.  Effects of ritanserin on aversive classical conditioning in humans.  Psychopharmacology 1991; 104: 220–224.

Hertzberg MA, Feldman ME, Beckham JC, Davidson JR.  Trial of trazodone for post-traumatic stress  disorder using a multiple baseline group design.  J Clin Psychopharmacol 1996; 16: 294–298.

Joseph MH, Kennell GA.  Corticosteroid response to stress  depends upon increased tryptophan availability.  Psychopharmacology 1983; 79: 79–81.

Kline NA, Dow BM, Brown SA, Matloff JA.  Sertraline efficacy in depressed combat veterans with post-traumatic stress  disorder.  Am J Psychiatry 1994; 151: 621.

Kulka RA, Schlenger WE, Fairbank JA et al.  Trauma and the Vietnam War generation: report of the findings of the National Vitnam Veterans’ Readjustment study.  New York, NY: Brunner/Mazel, 1990.

Marmar CR, Schoenfield F, Weiss D et al.  Open trial of fluvoxamine treatment for combat-related post-traumatic stress  disorder.  J Clin Psychiatry 1996; 14: 79–81.

Marshall RD, Stein DJ, Liebowitz MR, Yehuda R.  A pharmacotherapy algorithm in the treatment of post-traumatic stress  disorder.  Psychiatry Ann 1996; 26: 217–226.

McDougle CJ, Southwick SM, Charney DS, St. James RI.  An open clinical trial of fluoxetine in the treatment of post-traumatic stress  disorder.  J Clin Psychopharmacol 1991; 11: 325–327.

Nagy LM, Morgan CA, Southwick SM, Charney DS.  Open prospective trial of fluoxetine for post-traumatic stress  disorder.  J Clin Psychopharmacol 1993; 13: 107–114.

Penava SJ, Otto MW, Pollack MH, Rosenbaum JF.  Current status of pharmacotherapy for PTSD: an effect size analysis of controlled studies.  Depress Anxiety 1996–97; 4: 240–242.

Rauch SL, Shin LM, Whalen PJ, Pitman RK.  Neuroimaging and the neuroanatomy of post-traumatic stress  disorder.  CNS Spectrums 1998; 7S: 30–41.

Rothbaum RO, Foa EB, Rigge DS, Murdoch T, Walsh W.  A prospective examination of post-traumatic stress  disorder in rape victims.  J Trauma Stress  1992; 5: 455–475.

Rothbaum BO, Ninan PT, Thomas L.  Sertraline in the treatment of rape victims with post-traumatic stress  disorder.  J Trauma Stress  1996; 9: 865–871.

Shay J.  Fluoxetine reduces explosiveness and elevates mood of Vietnam combat veterans with PTSD.  J Trauma Stress  1992; 5: 97–101.

Solomon SD, Davidson JRT.  Trauma: prevalence, impairment, service use, and cost.  J Clin Psychiatry 1997; 58S: 5–11.

Solomon SD, Gerrity ET, Muff AM.  Efficacy of treatments for post-traumatic stress  disorder: an empirical review.  JAMA 1992; 268: 633–638.

Southwick SM, Yehuda R, Morgan CA III.  Clinical studies of neurotransmitter  alterations in post-traumatic stress  disorder.  In:  Friedman MJ, Charney DS, Deutch AY, eds.  Neurobiology and clinical consequences of stress: from normal adaptation to PTSD.  New York, NY:  Lippincott-Raven, 1995: 335–349.

van der Kolk BA.  The psychobiology of post-traumatic stress  disorder.  J Clin Psychiatry 1997; 58S: 16–24.

van der Kolk BA, Dreyfuss D, Michaels M et al.  Fluoxetine in post-traumatic stress  disorder.  J Clin Psychiatry 1994; 55: 517–522.

Yehuda R.  Recent developments in the neuroendocrinology of post-traumatic stress  disorder.  CNS Spectrums 1998; 7S: 22–29.

Yehuda R, McFarlane AC.  Conflict between current knowledge about post-traumatic stress  disorder and its original conceptual basis.  Am J Psychiatry 1995; 152: 1705–1713.

Last updated: 20.12.2011